Results 191 to 200 of about 277,288 (290)
Genomic medicine for heart failure prediction in patients with atrial fibrillation. [PDF]
Wijdeveld LFJM, Jurgens SJ.
europepmc +1 more source
Jan Swammerdam (1637–1680). His Life and Worksby A. Schierbeek, Amsterdam, Swets & Zeitlinger, 1967, pp. vi, 202, illus., no price stated. [PDF]
Bernard Towers
openalex +1 more source
Pemetrexed is a cornerstone in chemo(immunotherapy) of non‐small cell lung cancer and mesothelioma; however, it is contraindicated in patients with renal impairment due to severe toxicity concerns. Therefore, a large proportion of patients is withheld from effective chemo(immunotherapy).
Nikki de Rouw+18 more
wiley +1 more source
Tailored Care for Dementia Patients with Cerebrovascular Pathology. [PDF]
van de Schraaf SAJ, Muller M.
europepmc +1 more source
A. Heyting, Axiomatic Projective Geometry (Noordhoff-Groningen; North-Holland Publishing Co., Amsterdam, 1963.), xii + 148 pp., 36s. [PDF]
Donald Monk
openalex +1 more source
The potential of real‐world data (RWD), particularly from patient registries, has been increasingly recognized over the last decade by academia, regulators, and health technology assessment (HTA) bodies for its role in assessing a product's effectiveness and supporting regulatory submissions.
Sonia Zebachi+13 more
wiley +1 more source
Busulfan is administered intravenously in conditioning regimens prior to allogeneic hematopoietic stem cell transplantation (HSCT), with model‐informed precision dosing (MIPD) targeting a 4‐day cumulative AUC of 80–100 mg*hour/L. Three pharmacokinetic (PK) models—Bognar, Langenhorst, and McCune—were evaluated using data with a minimum of 1 and a median
Rashudy F. Mahomedradja+13 more
wiley +1 more source
Subcortical gray matter volumes and 5-year dementia risk in individuals with subjective cognitive decline or mild cognitive impairment: A multi-cohort analysis. [PDF]
Rosbergen MT+10 more
europepmc +1 more source